These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes. Humar A; Crotteau S; Gruessner A; Kandaswamy R; Gruessner R; Payne W; Lake J Clin Transplant; 2007; 21(4):526-31. PubMed ID: 17645714 [TBL] [Abstract][Full Text] [Related]
26. Safety and effectiveness of intensive insulin protocol use in post-operative liver transplant recipients. Keegan MT; Vrchota JM; Haala PM; Timm JV Transplant Proc; 2010 Sep; 42(7):2617-24. PubMed ID: 20832556 [TBL] [Abstract][Full Text] [Related]
27. Comparison of results of combined liver-kidney transplantation vs. isolated liver transplantation. Aguilera V; Ferrer I; Berenguer M; Rivera J; Rubín Á; Moya Á; Pareja E; Sánchez J; Prieto M; Mir J Ann Hepatol; 2013; 12(2):274-81. PubMed ID: 23396739 [TBL] [Abstract][Full Text] [Related]
28. Short-term outcomes of paediatric liver transplant recipients after transition to Adult Healthcare Service. Ferrarese A; Germani G; Lazzaro S; Cananzi M; Russo FP; Senzolo M; Gambato M; Zanetto A; Cillo U; Gringeri E; Perilongo G; Burra P Liver Int; 2018 Jul; 38(7):1316-1321. PubMed ID: 29205755 [TBL] [Abstract][Full Text] [Related]
29. The Degree of Hyperglycemia Excursion in Patients of Kidney Transplantation (KT) or Liver Transplantation (LT) Assessed by Continuous Glucose Monitoring (CGM): Pilot Study. Jin HY; Lee KA; Kim YJ; Park TS; Lee S; Park SK; Hwang HP; Yang JD; Ahn SW; Yu HC J Diabetes Res; 2019; 2019():1757182. PubMed ID: 31886275 [TBL] [Abstract][Full Text] [Related]
30. Perioperative Glycemic Surveillance and Control-Current Practices, Efficacy and Impact on Postoperative Outcomes following Infrainguinal Vascular Intervention. Kinio AE; Gold M; Doonan RJ; Steinmetz O; Mackenzie K; Obrand D; Girsowicz E; Bayne J; Gill HL Ann Vasc Surg; 2023 Sep; 95():108-115. PubMed ID: 37003358 [TBL] [Abstract][Full Text] [Related]
31. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Jain A; Kashyap R; Demetris AJ; Eghstesad B; Pokharna R; Fung JJ Liver Transpl; 2002 Jan; 8(1):40-6. PubMed ID: 11799484 [TBL] [Abstract][Full Text] [Related]
33. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490 [TBL] [Abstract][Full Text] [Related]
34. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database. Simpson N; Cho YW; Cicciarelli JC; Selby RR; Fong TL Transplantation; 2006 Nov; 82(10):1298-303. PubMed ID: 17130778 [TBL] [Abstract][Full Text] [Related]
35. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome. Rodríguez-Perálvarez M; Germani G; Papastergiou V; Tsochatzis E; Thalassinos E; Luong TV; Rolando N; Dhillon AP; Patch D; O'Beirne J; Thorburn D; Burroughs AK J Hepatol; 2013 Feb; 58(2):262-70. PubMed ID: 23023010 [TBL] [Abstract][Full Text] [Related]
36. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604 [TBL] [Abstract][Full Text] [Related]
37. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Miles AM; Sumrani N; Horowitz R; Homel P; Maursky V; Markell MS; Distant DA; Hong JH; Sommer BG; Friedman EA Transplantation; 1998 Feb; 65(3):380-4. PubMed ID: 9484755 [TBL] [Abstract][Full Text] [Related]
38. Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients. Cauchy F; Vibert E; Cherqui D; Perdigao F; Sepulveda A; Samuel D; Calmus Y; Conti F; Adam R; Soubrane O; Scatton O Transplantation; 2020 Jul; 104(7):1403-1412. PubMed ID: 31651789 [TBL] [Abstract][Full Text] [Related]
39. Anti-CD25 monoclonal antibody replacement therapy for chronic kidney disease in liver transplant recipients. Walsh C; Barkun J; Tchervenkov J; Deschenes M; Ghali P; Wong P; Chaudhury P; Paraskevas S; Metrakos P; Cantarovich M Transplantation; 2013 Feb; 95(3):495-500. PubMed ID: 23296149 [TBL] [Abstract][Full Text] [Related]
40. Modifiable Variables Are Major Risk Factors for Posttransplant Diabetes Mellitus in a Time-Dependent Manner in Kidney Transplant: An Observational Cohort Study. de Lucena DD; de Sá JR; Medina-Pestana JO; Rangel ÉB J Diabetes Res; 2020; 2020():1938703. PubMed ID: 32258163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]